scholarly journals Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein

1997 ◽  
Vol 94 (10) ◽  
pp. 4943-4947 ◽  
Author(s):  
R. Knee ◽  
A. W. Li ◽  
P. R. Murphy
Diabetes ◽  
1992 ◽  
Vol 41 (2) ◽  
pp. 222-226 ◽  
Author(s):  
C. W. Karpen ◽  
R. G. Spanheimer ◽  
A. L. Randolph ◽  
W. L. Lowe

Diabetes ◽  
1992 ◽  
Vol 41 (2) ◽  
pp. 222-226 ◽  
Author(s):  
C. W. Karpen ◽  
R. G. Spanheimer ◽  
A. L. Randolph ◽  
W. L. Lowe

1995 ◽  
Vol 6 (12) ◽  
pp. 1861-1873 ◽  
Author(s):  
J D Coffin ◽  
R Z Florkiewicz ◽  
J Neumann ◽  
T Mort-Hopkins ◽  
G W Dorn ◽  
...  

Basic fibroblast growth factor (FGF-2) is a pleiotropic growth factor detected in many different cells and tissues. Normally synthesized at low levels, FGF-2 is elevated in various pathologies, most notably in cancer and injury repair. To investigate the effects of elevated FGF-2, the human full-length cDNA was expressed in transgenic mice under control of a phosphoglycerate kinase promoter. Overexpression of FGF-2 caused a variety of skeletal malformations including shortening and flattening of long bones and moderate macrocephaly. Comparison by Western blot of FGF-2 transgenic mice to nontransgenic littermates showed expression of human FGF-2 protein in all major organs and tissues examined including brain, heart, lung, liver, kidney, spleen, and skeletal muscle; however, different molar ratios of FGF-2 protein isoforms were observed between different organs and tissues. Some tissues preferentially synthesize larger isoforms of FGF-2 while other tissues produce predominantly smaller 18-kDa FGF-2. Translation of the high molecular weight isoforms initiates from unconventional CUG codons and translation of the 18-kDa isoform initiates from an AUG codon in the FGF-2 mRNA. Thus the Western blot data from the FGF-2 transgenic mice suggest that tissue-specific expression of FGF-2 isoforms is regulated translationally.


1995 ◽  
Vol 312 (2) ◽  
pp. 609-615 ◽  
Author(s):  
E T Lau ◽  
D Cao ◽  
C Lin ◽  
S K Chung ◽  
S S Chung

Aldose reductase (AR), the first enzyme in the polyol pathway, has been implicated in the pathogenesis of diabetic complications, although its physiological role is unclear. In mice, besides AR, two AR-like proteins, mouse vas deferens protein (MVDP) and fibroblast growth factor-regulated protein (FR-1), have been reported recently. Tissue-specific expression of these two genes was examined using the RNase protection assay method. Contrary to previous reports, MVDP was detected in a variety of tissues besides the vas deferens. High levels of MVDP mRNA were found in the adrenal glands, and low levels of expression were detected in eye, intestine, seminal vesicle, kidney, liver, testis and lung. The major gene expression pattern for FR-1 was slightly different from that of MVDP, with the highest levels of mRNA detected in testis, heart, adrenal gland, and ovary; less was found in the lung and it was barely detectable in eye, intestine, liver and seminal vesicle tissue. Mouse embryos, as early as 10.5 days post coitum, expressed both genes, although the levels of expression were different. Human AR mRNA was found in human vas deferens, although not at the high level found in mice. The localization of both MVDP and FR-1 transcripts in the adrenal cortex by in situ hybridization led to the speculation that these two AR-like proteins could be related to hormone production.


2006 ◽  
Vol 68 (3) ◽  
pp. 248-250 ◽  
Author(s):  
Shuko OKADA ◽  
Takashi MASU ◽  
Takahiko TSUNODA ◽  
Ryuhei OKUYAMA ◽  
Setsuya AIBA

Sign in / Sign up

Export Citation Format

Share Document